lobbying_activities: 3185289
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3185289 | 471e1c10-ef06-401b-b963-e58300190183 | Q2 | SLAIMAN CONSULTING LLC | 401104787 | ENANTA PHARMACEUTICALS | 2024 | second_quarter | HCR | Covid policies | SENATE | 0 | 0 | 2024-07-02T10:22:25-04:00 |